ArticleThe Australasian journal of dermatology2022

Thalidomide for prevention of camrelizumab-induced reactive cutaneous capillary endothelial proliferation.

Geng Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.